Laurence W. Lytton 13D and 13G filings for Catalyst Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 2:55 pm Sale |
2022-12-31 | 13G | Catalyst Biosciences, Inc. CBIO |
Laurence W. Lytton | 177,822 7.100% |
-294,793 (-62.37%) |
Filing |
| 2022-03-04 5:23 pm Purchase |
2022-02-22 | 13G | Catalyst Biosciences, Inc. CBIO |
Laurence W. Lytton | 472,615 5.900% |
442,952 (+1493.26%) |
Filing |